Tempus AI, Inc. Class A Common Stock(TEM)— 同業公司組

數據截至2026-09-21 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Tempus AI, Inc. Class A Common Stock的Closelook綜合評分為38/100,在同業公司組內排名第7位(共7家)——組內評分最高的是BB Biotech AG(74/100)。

名稱綜合動能品質估值訊號距52週高點
TEM Tempus AI, Inc. Class A Common Stock38641816bull25.4%
VEEV Veeva Systems Inc Class A59797430neutral16.2%
BTSG BrightSpring Health Services, Inc. Common Stock47552539info24.3%
BION.SW BB Biotech AG74709680info9.1%
ARGX.BR Argen-X65817527ok6.2%
DXCM DexCom Inc65858035bull3.5%
ARGX argenx NV ADR64767426ok7.9%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板

FAQ · from the current data · as of 2026-09-21

Quick answers

Tempus AI, Inc. Class A Common Stock在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:Veeva Systems Inc Class A (VEEV)、BrightSpring Health Services, Inc. Common Stock (BTSG)、BB Biotech AG (BION.SW)、Argen-X (ARGX.BR)、DexCom Inc (DXCM)、argenx NV ADR (ARGX)。

TEM相對同業公司的評分如何?

Tempus AI, Inc. Class A Common Stock的綜合評分為38/100,組內排名第7位(共7家),截至2026-09-21;組內最高綜合評分為BB Biotech AG(74/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelook universe

then Health Information Services, then Healthcare. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.